---
$id: https://graph.org.ai/products/commodity/51433201
$type: Product
source: UNSPSC
code: "51433201"
title: "Ambrisentan"
class: "51433200"
classTitle: "Antihypertensive phenylpropionates"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ambrisentan

**UNSPSC Code**: 51433201
**Class**: [Antihypertensive phenylpropionates](Antihypertensive phenylpropionates.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an endothelin-1 protein receptor antagonist and antihypertensive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HW6NV07QEC. European Medicines Agency schedules Ambrisentan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25424. Ambrisentan generally arises in the molecular formula C22H22N2O4. The term AMBRISENTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., no. 1.2002, list 47.) Most nations schedule ambrisentan under HS 29335995 and SITC 51576. As of Q4 2014, AMBRISENTAN remains the US FDA Preferred Term for this commodity. Ambrisentan bears US NLM identifiers UMLS ID C1176329 and NCI Concept Code C72694. SMILES: O(C(C(Oc1nc(cc(n1)C)C)C(=O)O)(c1ccccc1)c1ccccc1)C.

